Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 25, 2015 9:38 PM ET


Company Overview of Diffusion Pharmaceuticals LLC

Company Overview

Diffusion Pharmaceuticals LLC, a clinical-stage biotechnology company, develops drugs that target the unmet medical needs characterized by hypoxia at the cellular level. The company engages in the development, formulation, clinical testing, manufacture, and commercialization of small-molecule drugs that help regulate the movement of oxygen into tissue by a mechanism of action. Its development portfolio includes trans sodium crocetinate, a drug used for the treatment of solid cancerous tumors. The company was founded in 2001 and is based in Charlottesville, Virginia.

2020 Avon Court

Suite 4

Charlottesville, VA 22902

United States

Founded in 2001





Key Executives for Diffusion Pharmaceuticals LLC

Co-Founder, Chief Executive Officer and Director
Co-Founder, Chairman of Scientific Advisory Board, Chief Scientific Officer and Director
Chief Financial Officer and Treasurer
Chief Medical Officer and Member of Scientific Advisory Board
Secretary, Senior Patent Strategist and Director
Compensation as of Fiscal Year 2014.

Diffusion Pharmaceuticals LLC Key Developments

Diffusion Pharmaceuticals LLC Presents at 17th Annual BIO CEO & Investor Conference, Feb-10-2015 09:30 AM

Diffusion Pharmaceuticals LLC Presents at 17th Annual BIO CEO & Investor Conference, Feb-10-2015 09:30 AM. Venue: The Waldorf Astoria, New York, New York, United States.

Diffusion Pharmaceuticals LLC Presents at 8th Annual OneMedForum 2015, Jan-12-2015

Diffusion Pharmaceuticals LLC Presents at 8th Annual OneMedForum 2015, Jan-12-2015 . Venue: San Francisco Marriott Marquis, Parc 55 Wyndham, Union Square, San Francisco, California, United States.

Diffusion Pharmaceuticals Clinical Trial of TSC in Brain Cancer Reaches One Year Interim Endpoint

Diffusion Pharmaceuticals LLC announced that it has reached the one year interim endpoint for its Phase I/II clinical trial of trans sodium crocetinate (TSC), the Company's lead compound for the treatment of cancer. The study enrolled 59 patients with newly diagnosed primary brain cancer (glioblastoma multiforme or GBM) at 18 major U.S. cancer centers. GBM is a deadly cancer, with only 61% of patients alive one year after diagnosis and about 26% at two years. The Diffusion study is designed to determine whether adding TSC to the current standard-of-care treatment for GBM can significantly improve survival. At the one year interim mark, the Diffusion clinical trial results surpass the historical standard of care. Further information has been submitted for presentation in connection with a major oncology medical meeting being held later in the year.

Similar Private Companies By Industry

Company Name Region
Azopharma Product Development Group, Inc. United States
TotipotentRx Corporation United States
Pharmexa Epimmune Inc. United States
PharmaNutrients, Inc. United States
St. Paul Pharmaceutical, Inc. United States

Recent Private Companies Transactions

Private Placement
June 30, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Diffusion Pharmaceuticals LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at